David M. Urso - 01 Jul 2021 Form 4 Insider Report for MEI Pharma, Inc. (MEIP)

Role: Chief Operating Officer & GC
Signature: /s/ Brian G. Drazba, as attorney in fact
Issuer symbol: MEIP
Transactions as of: 01 Jul 2021
Net transactions value: -$72,986
Form type: 4
Filing time: 06 Jul 2021, 18:49:31 UTC
Next filing: 07 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEIP	Common Stock	Tax liability	$72,986	-24,825	-33%	$2.94	49,281	02 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEIP	Stock Option (Right to Buy)	Award	$0	+600,000		$0.000000	600,000	01 Jul 2021	Common Stock	600,000	$2.95	Direct	F2
holding	MEIP	Stock Option (Right to Buy)						127,500	01 Jul 2021	Common Stock	127,500	$1.57	Direct	F3
holding	MEIP	Stock Option (Right to Buy)						130,000	01 Jul 2021	Common Stock	130,000	$1.36	Direct	F3
holding	MEIP	Stock Option (Right to Buy)						130,000	01 Jul 2021	Common Stock	130,000	$2.83	Direct	F3
holding	MEIP	Stock Option (Right to Buy)						130,000	01 Jul 2021	Common Stock	130,000	$4.33	Direct	F4
holding	MEIP	Stock Option (Right to Buy)						220,000	01 Jul 2021	Common Stock	220,000	$4.28	Direct	F5
holding	MEIP	Stock Option (Right to Buy)						350,000	01 Jul 2021	Common Stock	350,000	$2.52	Direct	F6
holding	MEIP	Stock Option (Right to Buy)						525,000	01 Jul 2021	Common Stock	525,000	$3.49	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units.
F2	One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
F3	All of such options are presently exercisable.
F4	One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019.
F5	One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
F6	One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
F7	One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.